BSPS Blood Culture Analysis

The Frimley Health NHS Foundation Trust is initiating a procurement process for the "BSPS Blood Culture Analysis" to ensure compliance with new SMI guidelines under the UKPGA legal framework 2023/54. This planned tender involves delivering blood analysis services across multiple regions in the United Kingdom, including UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, and UKK. The contract is planned to commence on 1st May 2026 and conclude on 30th April 2032.

The industry category for this procurement is services, specifically focusing on blood analysis services (CPV code 85111810). The procurement stage is currently at the planning phase, with a future notice announcement expected by 1st October 2025. This tender presents a significant opportunity for businesses specializing in medical laboratory services, particularly those involved in blood analysis.

Companies with expertise in pathology services could greatly benefit from this long-term project to enhance their client base and revenue streams. The scale of this procurement, covering numerous geographic regions, makes it a suitable opportunity for businesses capable of delivering services at both regional and national levels. Such projects can lead to significant growth prospects, not only through direct engagement with the Frimley Health NHS Foundation Trust but also by expanding their reputation within the healthcare sector.